JPMorgan Funds - Thematics - Genetic Therapies I (acc) - EUR (0P0001M16D)

The fund primarily invests by dedicating a minimum of 80% of its capital to equity instruments and related securities that maintain an economic connection to emerging markets. For clarity, "assets" are defined as the fund's net assets combined with any funds borrowed for investment purposes. This strategy allows for investments in securities denominated in a range of currencies, including the U.S. dollar, other prominent reserve currencies such as the euro, Japanese yen, and British pound, and the local currencies of other countries where the fund is authorized to invest.